Showing 1 - 9 of 9
In 2002, a number of associations requested the Korean Patent Office to issue a compulsory license for the manufacture of a drug under the Korean patent provision which permits the issue of compulsory licensing for public non-commercial use. This provision in the Korean patent act was introduced...
Persistent link: https://www.econbiz.de/10005812411
Persistent link: https://www.econbiz.de/10003350680
Persistent link: https://www.econbiz.de/10003588017
Persistent link: https://www.econbiz.de/10001705004
Persistent link: https://www.econbiz.de/10001724570
Persistent link: https://www.econbiz.de/10001880838
The TRIPS Agreement recognizes abuses inherent in the IP monopoly along with the fact that competition policy plays a significant role in dealing with such abuses. The relationship of competition policy with intellectual property rights has three important dimensions: (a) where the abuse...
Persistent link: https://www.econbiz.de/10014072610
In 2002, a number of associations requested the Korean Patent Office to issue a compulsory license for the manufacture of Gleevec, a drug under Novartis' patent under the Korean patent provision which permits issue of compulsory licensing for public non-commercial use. This provision in the...
Persistent link: https://www.econbiz.de/10014075687
The period 1962-89 witnessed a remarkable transformation of the South Korean economy, from being poverty ridden to the attainment of the status of newly industrialised nation. This transformation was achieved through the adoption of an outward oriented industry led strategy, based, particularly...
Persistent link: https://www.econbiz.de/10005227253